Prediction Markets Bet on US Health Crises as Measles and Vaccine Mandates Enter the Spotlight

Prediction markets move into public health

Online prediction platforms that once focused on elections, sports and cryptocurrency prices are now offering contracts tied to public health events in the United States. Two of the most visible operators, Polymarket and Kalshi, have added markets that let participants place bets on the likelihood of measles outbreaks, the adoption of state vaccine mandates and the success of clinical trials for new medicines.

How Polymarket and Kalshi operate

Both platforms function as decentralized or regulated exchanges where users trade binary or scalar contracts. A binary contract pays out a fixed amount if a specified outcome occurs, while a scalar contract offers a payout that varies with the magnitude of the result. Users fund their accounts with cryptocurrency or fiat currency, select a market, and buy or sell shares based on their expectations.

Polymarket, founded in 2020, runs on a blockchain infrastructure that provides transparency of trades but limited oversight. Kalshi, a Chicago‑based exchange, is registered with the Commodity Futures Trading Commission (CFTC) and must adhere to U.S. financial regulations. The two models illustrate the spectrum of legal compliance in the emerging prediction‑market space.

The specific health bets now on the table

Measles outbreak forecasts

One of the newest contracts asks whether the number of confirmed measles cases in the United States will exceed 1,000 by the end of 2024. The market reflects recent spikes in cases across states such as New York, California and Texas, where vaccination rates have fallen below the herd‑immunity threshold.

Vaccine mandate market

Another contract asks if any state will pass a law requiring COVID‑19 vaccination for public‑sector employees by June 2025. The question appears on a flyer posted outside a Brooklyn elementary school, where the phrase "Will any state end vaccine markets?" is printed beneath a pro‑vaccination graphic.

Drug trial outcome bets

Kalshi has opened a market on the success of a Phase III trial for a novel antiviral aimed at treating respiratory syncytial virus (RSV). Traders can wager on whether the trial will meet its primary endpoint, a result that could influence the drug’s market approval and pricing.

Ethical and legal concerns

Conflict of interest and public health

Critics argue that allowing financial speculation on health outcomes creates a perverse incentive. If large sums are wagered on a disease spreading, there is a risk that some participants might seek to influence public perception or policy to profit from their positions.

• Financial gain could motivate the spread of misinformation about vaccine safety.
• Market participants might lobby for or against health measures that affect contract payouts.
• Public trust in health agencies could erode if people perceive that health decisions are driven by market forces.

Regulatory landscape

Currently, the CFTC oversees commodity futures and options, but its authority over prediction markets that focus on non‑financial events is still evolving. The Securities and Exchange Commission (SEC) has signaled interest in clarifying the status of these platforms, while the Food and Drug Administration (FDA) monitors drug‑trial related speculation for potential market manipulation.

State health departments have not yet issued guidance on how to handle betting on disease metrics. The lack of a unified framework leaves regulators scrambling to address potential abuses.

Expert opinions on betting on health crises

Risks highlighted by epidemiologists

Dr. Maya Patel, an epidemiologist at the University of Washington, warns that “prediction markets can amplify uncertainty when they become a source of news for the public.” She notes that markets often react to rumors before official data are released, which can distort public understanding of disease trends.

Potential for misinformation

A recent analysis by the Center for Disease Control and Prevention (CDC) emphasizes that misinformation spreads faster on social media than factual updates. When betting platforms publicize market odds, they may unintentionally provide a headline that fuels speculation.

For instance, a surge in bets that a measles outbreak will exceed 1,000 cases could be reported by news outlets, prompting readers to assume the event is imminent even if the probability remains low.

What this means for the public

How bettors can protect themselves

Participants should treat health‑related contracts as high‑risk investments. Experts recommend the following safeguards:

1. Verify data sources before placing a bet; rely on official reports from the CDC or the World Health Organization (WHO).
2. Limit exposure to a small portion of one’s portfolio, as outcomes are often unpredictable.
3. Stay informed about policy changes that could affect market outcomes, such as new vaccine legislation.

Role of policymakers

Lawmakers face a choice: impose stricter oversight on prediction markets that touch on public health, or integrate these platforms into existing surveillance systems to harness crowd‑sourced insights. Some argue that regulated markets could provide early warning signals for emerging threats, while others fear they will become tools for profit‑driven actors.

In the meantime, public health agencies are urged to develop clear communication strategies that separate scientific data from market speculation.

As the line between finance and health continues to blur, the debate over whether betting on disease outbreaks is a harmless curiosity or a dangerous gamble is likely to intensify.